Cellia Science Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 2

Cellia Science General Information

Description

Developer of commercialized blood cell analyzer technology designed to provide rapid, actionable blood cell counts in any setting from the clinic to the home. The company offers point-of-care hematology through the development of devices by utilize the inherent UV absorbance of nucleic acids and proteins within cells and are capable of identifying full white blood cell differentials, enabling labs to test with just a drop of blood from a finger prick or venous sample.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 535 West Research Center Boulevard
  • Suite 135
  • Fayetteville, AR 72701
  • United States
+1 (479)
Primary Industry
Diagnostic Equipment
Corporate Office
  • 535 West Research Center Boulevard
  • Suite 135
  • Fayetteville, AR 72701
  • United States
+1 (479)

Cellia Science Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellia Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 13-Jun-2025 $2M Completed Startup
4. Grant 09-Oct-2023 Completed Startup
3. Early Stage VC 26-May-2023 Completed Startup
2. Grant 15-Feb-2023 $1.8M $250K Completed Startup
1. Early Stage VC 15-Nov-2022 $250K $250K Completed Startup
To view Cellia Science’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cellia Science Patents

Cellia Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025188609-A1 Methods and systems for assessment of biological specimen adequacy Pending 05-Mar-2024
WO-2025188609-A8 Methods and systems for assessment of biological specimen adequacy Pending 05-Mar-2024
US-20240189820-A1 Cell imaging and compression system and methods of use thereof Pending 08-Dec-2022 B01L3/50273

Cellia Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellia Science Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
VIC Technology Venture Development Venture Capital Minority
To view Cellia Science’s complete investors history, request access »

Cellia Science FAQs

  • When was Cellia Science founded?

    Cellia Science was founded in 2021.

  • Where is Cellia Science headquartered?

    Cellia Science is headquartered in Fayetteville, AR.

  • What is the size of Cellia Science?

    Cellia Science has 3 total employees.

  • What industry is Cellia Science in?

    Cellia Science’s primary industry is Diagnostic Equipment.

  • Is Cellia Science a private or public company?

    Cellia Science is a Private company.

  • What is Cellia Science’s current revenue?

    The current revenue for Cellia Science is .

  • How much funding has Cellia Science raised over time?

    Cellia Science has raised $300K.

  • Who are Cellia Science’s investors?

    National Institutes of Health and VIC Technology Venture Development have invested in Cellia Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process